Advantages of the Promomed Group's innovative drug Brainmax® discussed at Neuroforum
At the satellite symposium organized by Promomed Group at Neuroforum-2022, experts from medical community discussed the problem of cerebrovascular diseases and possible ways to expand multifactorial neuroprotective therapy in patients with stroke, cognitive impairment and asthenic conditions, including those caused by coronavirus infection, using the Promomed Group's original innovative drug Brainmax®.
The symposium was attended by speakers: Marine Tanashyan, Corresponding Member of the Russian Academy of Sciences, Deputy Director of the Research Center of Neurology (RCN), Anton Raskurazhev, Cand. Med. Sci., senior researcher at RCN, Marina Maksimova, Doct. Med. Sci., professor, Galina Belskaya, Doct. Med. Sci., professor, Honored Doctor of the Russian Federation.
The experts made presentations and discussed the mechanisms of combination treatment of patients with neurological disorders and the benefits of Brainmax® in this treatment. They highlighted its unique properties including:
– multimodality of therapeutic effects that allow a comprehensive approach to treatment and rehabilitation;
– enhanced effectiveness compared to traditional therapy due to the combined effects of the components of Brainmax® composition;
– the ability to influence all parts in the pathogenesis of acute and chronic cerebrovascular diseases;
– solving therapeutic tasks at three levels: neuronal, vascular and metabolic;
– a wide range of clinical efficacy compared to traditional therapy (protection, recovery, activation).
Brainmax® is an innovative drug developed by Russian scientists and technologists of Promomed specifically for patient suffering from chronic fatigue, attention disorders, and memory impairment. The composition of trimethylhydrazinium propionate and ethylmethylhydroxypyridine succinate has a pronounced synergistic effect and has a wide spectrum of action. The drug has a pronounced neuroprotective effect, is able to optimize cell function, restore the processes of oxygen delivery to the cell and its consumption even in hypoxia conditions. Brainmax®improves functioning of brain cells, normalizes emotional condition; removes chronic fatigue, increases the body vitality and performance, enhances the capability during hard work and high physical exertion and after illness (including COVID-19), protects the heart and increases the exercise tolerance.
The Neuroforum-2022 is the largest specialized event for discussing the problems of diagnosis and treatment of neurological disorders. This is a high-profile annual event for neurologists, neurosurgeons, cardiologists, critical care physicians, geneticists, therapists, general practitioners, radiologists, rehabilitation therapists and pharmacists.
